Zicam Maker Matrixx Settles With Shareholders Over H.I.G. Buyout
This article was originally published in The Tan Sheet
Executive Summary
Matrixx Initiatives remains mired in multiple lawsuits despite settling litigation with shareholders over the firm’s handling of its 2010 buyout.
You may also be interested in...
Supreme Court's Matrixx Decision Expands Firms' Disclosure Burden
The Supreme Court's decision in a complaint shareholders brought against Matrixx Initiatives lowers the threshold for when firms need to disclose information, but also aims to prevent an "avalanche of trivial information."
Matrixx Bought By Private Equity Firm H.I.G., Settles Personal Injury Lawsuits
Matrixx Initiatives announced Dec. 14 private equity firm H.I.G. Capital will acquire the Scottsdale, Ariz.-based maker of Zicam cough/cold products for approximately $75.2 million.